Netherlands· NL-d1efea36355a

CYCLOGYL 1% oogdruppels, oplossing

A cyclopentolate product containing cyclopentolaathydrochloride, registered in Netherlands by Alcon Nederland B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC S01FA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cyclopentolaathydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cyclopentolate is registered in 16 of 19 countries.

Countries holding a registration under ATC S01FA04 (cyclopentolate), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search cyclopentolate products by name

Cyclopentolate · ATC S01FA04

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: CYCLOPENTOLAATHYDROCHLORIDE
Manufacturer: Alcon Nederland B.V.
Country: Netherlands (NL)
ATC code: S01FA04
ATC class: Cyclopentolate
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
06851

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for cyclopentolate.

Graded by severity as the source publishes them — 3 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cyclopentolate against other medicines How interaction checks work

Cyclopentolate · interactions on record

3 records

3 moderate

Most severe, free to view

PhenylephrineC01CA06moderate
PhysostigmineS01EB05moderate
PhysostigmineV03AB19moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cyclopentolate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cyclopentolate products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

Belgium · Cyclogyl, Minims Cyclopentolaathydrochloride Bausch + Lomb Ireland Limited
Bulgaria · Цикловижън
Cyprus · Cyclogyl
Czechia · Cyclopentolate Olikla
Germany · Cyclopentolat Alcon, Zyklolat Edo
Denmark · Cyclogyl
Spain · Colirofta Ciclopléjico
Finland · Oftan Syklo
France · Skiacol
Greece · Cyclogyl
Hungary · Humapent
Ireland · Minims
Iceland · Cyclogyl
Italy · Ciclolux, Plegik
Lithuania · Cyclogyl
Luxembourg · Minims, Minims Cyclopentolate Chlorhydrate Bausch + Lomb Ireland Limited
Malta · Minims Cyclopentolate Hydrochloride Bausch + Lomb Ireland
Norway · Cyclopentolat Bausch + Lomb Ireland Limited
Poland · Cykloftyal
Portugal · Cicloplegicedol, Midriodavi
Sweden · Cyclogyl, Cyclopentolat Bausch & Lomb
Slovakia · Cyclopentolate Olikla

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/fbedbb4d-703b-4f65-9499-83b31d095cfd
GET /v1/drugs/fbedbb4d-703b-4f65-9499-83b31d095cfd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oogdruppels, oplossing",
  "route": "Oculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h06851_smpc.pdf",
  "strength": null,
  "atc_label": "Cyclopentolate",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg06851",
  "excipients": [
    "BENZALKONIUMCHLORIDE",
    "BOORZUUR (E 284)",
    "DINATRIUMEDETAAT 2-WATER",
    "KALIUMCHLORIDE (E 508)",
    "NATRIUMCARBONAAT 1-WATER (E 500 (I))",
    "WATER, GEZUIVERD",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "CYCLOPENTOLAATHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h06851.pdf",
  "authorised_at": "1974/03/06",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "06851",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about cyclopentolate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console